Add to Watchlist
View Current for JNJ
View SuperFeed for JNJ
View Charts for JNJ
Add or remove $JNJ from your watchlists:
Hang tight! We're updating your watchlist data.
This might take a minute...
Johnson & Johnson
Health Care
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwid… more
🤔 Insider Trades
$JNJ trades made by insiders of the company, Past 60 days. PRO TIP: Click+Drag your mouse to ZOOM IN!
Select Filters:
| Date | Name | Role | Type | Security Name | Amount or # of Shares |
| Jan. 17, 2023 | Gorsky Alex | Director | Sell |
Employee Stock Options (Right To Buy) | 547,692 |
| Jan. 17, 2023 | Duato Joaquin | Director | Sell |
Employee Stock Options (Right To Buy) | 148,538 |
| Jan. 17, 2023 | Gorsky Alex | Director | Sell |
Common Stock | 366,610 |
| Jan. 17, 2023 | Duato Joaquin | Director | Sell |
Common Stock | 98,795 |
| Jan. 17, 2023 | Gorsky Alex | Director | Buy |
Common Stock | 547,692 |
| Jan. 17, 2023 | Duato Joaquin | Director | Buy |
Common Stock | 148,538 |
| Dec. 13, 2022 | Wolk Joseph J | Officer: Exec Vp, Cfo | Sell |
Employee Stock Options (Right To Buy) | 12,926 |
| Dec. 13, 2022 | Wolk Joseph J | Officer: Exec Vp, Cfo | Sell |
Employee Stock Options (Right To Buy) | 1,855 |
| Dec. 13, 2022 | Wolk Joseph J | Officer: Exec Vp, Cfo | Sell |
Common Stock | 12,926 |
| Dec. 13, 2022 | Wolk Joseph J | Officer: Exec Vp, Cfo | Sell |
Common Stock | 1,855 |
| Dec. 13, 2022 | Wolk Joseph J | Officer: Exec Vp, Cfo | Buy |
Common Stock | 1,855 |
| Dec. 13, 2022 | Wolk Joseph J | Officer: Exec Vp, Cfo | Buy |
Common Stock | 12,926 |
| Dec. 6, 2022 | Weinberger Mark A | Director | Buy |
Deferred Share Units | 241 |
| Dec. 6, 2022 | Hewson Marillyn A | Director | Buy |
Deferred Share Units | 240 |
| Dec. 6, 2022 | Washington A. Eugene | Director | Buy |
Deferred Share Units | 350 |
🇺🇸 Congressional Trades
$JNJ trades made by members of the US Congress, Past 120 days
| Representative | Committees | Disclosed | Transaction Date | Details | Type | Stock |
Democrat, House
|
The Budget
Ways And Means
|
Jan. 5, 2023
(29 days after trade)
|
Dec. 7, 2022 |
small
$1,001 - $15,000
|
Buy
|
$JNJ
|
Republican, House
|
Ways And Means
|
Jan. 13, 2023
(38 days after trade)
|
Dec. 6, 2022 |
small
$1,001 - $15,000
|
Buy
|
$JNJ
|
Democrat, House
|
Energy And Commerce
|
Dec. 8, 2022
(30 days after trade)
|
Nov. 8, 2022 |
small
$1,001 - $15,000
|
Buy
|
$JNJ
|
|
Democrat, House
|
Energy And Commerce
|
Dec. 8, 2022
(30 days after trade)
|
Nov. 8, 2022 |
small
$1,001 - $15,000
|
Buy
|
$JNJ
|
Republican, House
|
Agriculture
The Budget
|
Dec. 12, 2022
(34 days after trade)
|
Nov. 8, 2022 |
small
$1,001 - $15,000
|
Buy
|
$JNJ
|
Democrat, House
|
Appropriations
Veterans' Affairs
|
Nov. 18, 2022
(23 days after trade)
|
Oct. 26, 2022 |
small
$1,001 - $15,000
|
Sell (Partial)
|
$JNJ
|
|
Democrat, House
|
Appropriations
Veterans' Affairs
|
Nov. 18, 2022
(23 days after trade)
|
Oct. 26, 2022 |
small
$1,001 - $15,000
|
Sell (Partial)
|
$JNJ
|
Democrat, House
|
Education And Labor
Foreign Affairs
|
Nov. 10, 2022
(29 days after trade)
|
Oct. 12, 2022 |
small
$1,001 - $15,000
|
Buy
|
$JNJ
|
|
Democrat, House
|
Education And Labor
Foreign Affairs
|
Nov. 10, 2022
(29 days after trade)
|
Oct. 12, 2022 |
small
$1,001 - $15,000
|
Buy
|
$JNJ
|
Recent Captain Alerts (Last 5)
Alerts are triggered when we detect unusually high conversation volume for $JNJ. Want real-time alerts? Use our Alerts Gadget.
| Alert Date | Alert Algorithm | Price At Alert | Recent Price | Conversation Volume Change | Analysts that triggered alert |
|---|---|---|---|---|---|
|
1675097650
[See Details]
|
Analyst A.I. | $163.80 | $164.86 (+0.6%) | +168% |
|
|
1674495015
[See Details]
|
Analyst A.I. | $168.18 | $164.86 (-2.0%) | +244% |
|
|
1674069851
[See Details]
|
Analyst A.I. | $170.06 | $164.86 (-3.1%) | +335% |
|
|
1673640248
[See Details]
|
Analyst A.I. | $173.27 | $164.86 (-4.9%) | +223% |
|
|
1672779250
[See Details]
|
Analyst A.I. | $177.71 | $164.86 (-7.2%) | +446% |
|
There is not enough conversation volume about this stock
Conviction History
Bullish vs Bearish Conviction over the last 30 days.
This color denotes Market Hours (US/Eastern)
There is not enough conversation volume about this stock
Thread Explorer
Explore popular threads around $JNJ
There are no threads for this stock
Go to Thread Explorer
Chart Explorer
Explore recent charts, graphs, and media
There are no charts for this stock
Rarely do we see this kind of divergence between value ($SPYV = black line) and growth ($SPYG = red line). Check it out this 5 year chart...
Go to Chart Explorer
Latest News
Get the latest breaking news from the community
There is no recent news for this stock
Loading news, hang tight...
Google Search Trends - Past 12 months
Instantly visualize search trends for this specific symbol
Company Profile
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.Market Cap Type: Large
